Related Experiment Video
Updated: Sep 15, 2025

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
Published on: June 28, 2019
A young-onset dementia case associated with PDGFRβ mutation
Ozlem Totuk1, Nazire Çelem1, Sevki Sahin1
1University of Health Sciences, Hamidiye Faculty of Medicine, Department of Neurology, Istanbul, Türkiye.
Abstract:
We report a case of young-onset dementia (YOD) in a 40-year-old male with a heterozygous missense variant in the PDGFRβ gene. The patient exhibited progressive memory decline and disorientation. Brain MRI and cerebrospinal fluid biomarkers were consistent with Alzheimer's disease. Whole-exome sequencing identified a likely pathogenic PDGFRB c.1316G > A (p.Arg439Gln) variant. This report highlights a novel potential genetic contributor to vascular dysfunction and cognitive decline.
Insights
A rare genetic variant in the PDGFRB gene may contribute to young-onset dementia (YOD). This finding offers new insights into the genetic causes of early-onset cognitive decline and vascular issues.
Area of Science:
- Neurogenetics
- Vascular Biology
- Dementia Research
Background:
- Young-onset dementia (YOD) presents before age 65 and has diverse etiologies.
- Genetic factors are increasingly recognized in the pathogenesis of YOD.
- Platelet-derived growth factor receptor beta (PDGFRβ) plays roles in vascular development and homeostasis.
Observation:
- A 40-year-old male presented with progressive memory loss and disorientation, clinically resembling Alzheimer's disease.
- Brain imaging and cerebrospinal fluid analysis supported an Alzheimer's disease diagnosis.
- Whole-exome sequencing was performed to investigate potential genetic underpinnings.
Findings:
- A heterozygous missense variant, c.1316G>A (p.Arg439Gln), was identified in the PDGFRB gene.
- This PDGFRB variant is classified as likely pathogenic.
- The identified variant suggests a potential novel genetic link to vascular dysfunction contributing to cognitive decline.
Implications:
- This case suggests PDGFRB variants as a potential cause of YOD.
- Understanding the role of PDGFRβ in vascular health may reveal new therapeutic targets for dementia.
- Further research is warranted to explore the functional consequences of PDGFRB variants in cognitive aging.
Related Concept Videos
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Alzheimer's Disease: Treatment

